|
1
|
Feng Q, Wei Y, Ren L, Zheng P, Yu Y, Ye Q,
Ding J, Chen J, Chang W, Zhong Y, et al: Efficacy of continued
cetuximab for unresectable metastatic colorectal cancer after
disease progression during first-line cetuximab-based chemotherapy:
A retrospective cohort study. Oncotarget. 7:11380–11396.
2016.PubMed/NCBI
|
|
2
|
Sali L, Mascalchi M, Falchini M, Ventura
L, Carozzi F, Castiglione G, Delsanto S, Mallardi B, Mantellini P,
Milani S, et al: Reduced and full-preparation CT colonography,
fecal immunochemical test, and colonoscopy for population screening
of colorectal cancer: A randomized trial. J Natl Cancer Inst.
108:pii: djv3192015. View Article : Google Scholar
|
|
3
|
Lok SW, Wong HL, Kosmider S, Field K, Tie
J, Desai J, Bae S, Tacey M, Skinner I, Jones I and Gibbs P:
Translation of clinical trial outcomes to metastatic colorectal
cancer patients in community practice. Asia Pac J Clin Oncol.
10:361–367. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maxwell AE, Danao LL and Bastani R:
Dissemination of colorectal cancer screening by Filipino American
community health advisors: A feasibility study. Health Promot
Pract. 14:498–505. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu XL, Lin KJ, Bai AP, Wang WX, Meng XK,
Su XL, Hou MX, Dong PD, Zhang JJ, Wang ZY and Shi L: Osteopontin
knockdown suppresses the growth and angiogenesis of colon cancer
cells. World J Gastroenterol. 20:10440–10448. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thomas J, Ohtsuka M, Pichler M and Ling H:
MicroRNAs: Clinical relevance in colorectal cancer. Int J Mol Sci.
16:28063–28076. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang JT, Wang JL, Du W, Hong J, Zhao SL,
Wang YC, Xiong H, Chen HM and Fang JY: MicroRNA 345, a
methylation-sensitive microRNA is involved in cell proliferation
and invasion in human colorectal cancer. Carcinogenesis.
32:1207–1215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma Y, Li W and Wang H: Roles of miRNA in
the initiation and development of colorectal carcinoma. Curr Pharm
Des. 19:1253–1261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong Y, Yu J and Ng SS: MicroRNA
dysregulation as a prognostic biomarker in colorectal cancer.
Cancer Manag Res. 6:405–422. 2014.PubMed/NCBI
|
|
10
|
Bandres E, Agirre X, Bitarte N, Ramirez N,
Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J:
Epigenetic regulation of microRNA expression in colorectal cancer.
Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Lu W, Saini SK, Moukha-Chafiq O,
Pathak V and Ananthan S: Identification of quinazoline compounds as
novel potent inhibitors of Wnt/β-catenin signaling in colorectal
cancer cells. Oncotarget. 7:11263–11270. 2016.PubMed/NCBI
|
|
12
|
Tarapore RS, Siddiqui IA, Adhami VM,
Spiegelman VS and Mukhtar H: The dietary terpene lupeol targets
colorectal cancer cells with constitutively active Wnt/β-catenin
signaling. Mol Nutr Food Res. 57:1950–1958. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Munding J, Ziebarth W, Pox CP, Ladigan S,
Reiser M, Hüppe D, Brand L, Schmiegel W, Tannapfel A and
Reinacher-Schick AC: The influence of 5-aminosalicylic acid on the
progression of colorectal adenomas via the β-catenin signaling
pathway. Carcinogenesis. 33:637–643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fonseca BF, Predes D, Cerqueira DM, Reis
AH, Amado NG, Cayres MC, Kuster RM, Oliveira FL, Mendes FA and
Abreu JG: Derricin and derricidin inhibit Wnt/β-catenin signaling
and suppress colon cancer cell growth in vitro. PLoS One.
10:e01209192015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu YZ, Wu K, Huang J, Liu Y, Wang X, Meng
ZJ, Yuan SX, Wang DX, Luo JY, Zuo GW, et al: The PTEN/PI3K/Akt and
Wnt/β-catenin signaling pathways are involved in the inhibitory
effect of resveratrol on human colon cancer cell proliferation. Int
J Oncol. 45:104–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim K, Chandrasekar E and Lam H:
Colorectal cancer screening among Chinese, cambodian, and
vietnamese immigrants in Chicago. J Racial Ethn Health Disparities.
2:473–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang QH, Sun HM, Zheng RZ, Li YC, Zhang
Q, Cheng P, Tang ZH and Huang F: Meta-analysis of microRNA-183
family expression in human cancer studies comparing cancer tissues
with noncancerous tissues. Gene. 527:26–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huangfu L, Liang H, Wang G, Su X, Li L, Du
Z, Hu M, Dong Y, Bai X, Liu T, et al: miR-183 regulates autophagy
and apoptosis in colorectal cancer through targeting of UVRAG.
Oncotarget. 7:4735–4745. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Q, Ren W, Huang B, Yi L and Zhu H:
MicroRNA-183/182/96 cooperatively regulates the proliferation of
colon cancer cells. Mol Med Rep. 12:668–674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou T, Zhang GJ, Zhou H, Xiao HX and Li
Y: Overexpression of microRNA-183 in human colorectal cancer and
its clinical significance. Eur J Gastroenterol Hepatol. 26:229–233.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bush BM, Brock AT, Deng JA, Nelson RA and
Sumter TF: The Wnt/β-catenin/T-cell factor 4 pathway up-regulates
high-mobility group A1 expression in colon cancer. Cell Biochem
Funct. 31:228–236. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong GZ, Shim AR, Hyeon JS, Lee HJ and Ryu
JH: Inhibition of Wnt/β-catenin pathway by dehydrocostus lactone
and costunolide in colon cancer cells. Phytother Res. 29:680–686.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu X, Deng G, Hao X, Li Y, Zeng J, Ma C,
He Y, Liu X and Wang Y: A caspase-dependent pathway is involved in
Wnt/β-catenin signaling promoted apoptosis in Bacillus
Calmette-Guerin infected RAW264.7 macrophages. Int J Mol Sci.
15:5045–5062. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takahashi K, Hosono M, Sato I, Hata K,
Wada T, Yamaguchi K, Nitta K, Shima H and Miyagi T: Sialidase NEU3
contributes neoplastic potential on colon cancer cells as a key
modulator of gangliosides by regulating Wnt signaling. Int J
Cancer. 137:1560–1573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang P and Li Z, Wang Y, Zhang L, Wu H and
Li Z: Secreted pyruvate kinase M2 facilitates cell migration via
PI3K/Akt and Wnt/β-catenin pathway in colon cancer cells. Biochem
Biophys Res Commun. 459:327–332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leung WK, He M, Chan AW, Law PT and Wong
N: Wnt/β-Catenin activates MiR-183/96/182 expression in
hepatocellular carcinoma that promotes cell invasion. Cancer Lett.
362:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
